About Estech Pharma
Estech Pharma is a company based in Hwaseong (South Korea) founded in 1996 by Kim Jae Cheol. The company has 164 employees as of December 31, 2024. Estech Pharma operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Hwaseong, South Korea
- Employees 164 as on 31 Dec, 2024
- Founders Kim Jae Cheol
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Polaris Ai Pharma Corp.
-
Annual Revenue
$40.41 M (USD)-7.18as on Dec 31, 2024
-
Net Profit
$2.68 M (USD)3.25as on Dec 31, 2024
-
EBITDA
$1.73 M (USD)-66.71as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
164
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Estech Pharma
Estech Pharma is a publicly listed company on the KRX with ticker symbol 041910 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Estech Pharma
Detailed funding history for Estech Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Estech Pharma
Investment portfolio details for Estech Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Estech Pharma
Detailed financials for Estech Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Estech Pharma Comparisons
Peer comparison for Estech Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Estech Pharma
Estech Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of Estech Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Estech Pharma
Complete news archive for Estech Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Estech Pharma
Estech Pharma was founded in 1996.
Estech Pharma is headquartered in Hwaseong, South Korea. It is registered at Hwaseong, Gyeonggi Province, South Korea.
Kim Jae Cheol is the current CEO of Estech Pharma. They have also founded this company.
As of Dec 31, 2024, the latest employee count at Estech Pharma is 164.
Annual revenue of Estech Pharma is $40.41M as on Dec 31, 2024.
Active pharmaceutical ingredients and intermediates are produced by Estech Pharma, which was established in 1996 in Hwaseong, South Korea. Operations focus on development and manufacturing within the pharmaceutical sector, utilizing GMP-certified laboratories. Expertise is applied to support pharmaceutical industry needs through these processes, ensuring compliance and quality standards are met.
Estech Pharma's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Yes, Estech Pharma is publicly traded on KRX under the ticker symbol 041910.
The ticker symbol of Estech Pharma is 041910 on KRX.